HMGB1 as a biomarker for myeloproliferative neoplasm complicated with atherosclerosis
Elevated levels of HMGB1 in the bone marrow and serum of MPN patients demonstrate a correlation with biochemical indices related to AS. This finding may serve as a valuable reference for predicting AS complications in MPN patients.
Authors
- Libo Jiang (ORCID: https://orcid.org/0000-0003-4703-9220)
- Shixu Zhang (ORCID: https://orcid.org/0000-0002-1240-3611)
- Y. Wang (ORCID: https://orcid.org/0000-0002-0271-626X)
- Lunbi Wu
- Wenxue Han (ORCID: https://orcid.org/0000-0003-2313-1516)
- Xiaodong Zhang (ORCID: https://orcid.org/0000-0002-7212-0138)
- Dongxue Han
- Bowen Jiang (ORCID: https://orcid.org/0000-0002-6878-3406)
- Huailei Chen
Institutions
- Qiqihar Medical University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-05-18
- DOI
- https://doi.org/10.1186/s40001-025-02655-8
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00